MRI as a screening tool for prostate cancer: current evidence and future challenges

PURPOSE: Prostate cancer (PCa) screening, which relies on prostate-specific antigen (PSA) testing, is a contentious topic that received negative attention due to the low sensitivity and specificity of PSA to detect clinically significant PCa. In this context, due to the higher sensitivity and specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Würnschimmel, Christoph, Chandrasekar, Thenappan, Hahn, Luisa, Esen, Tarik, Shariat, Shahrokh F., Tilki, Derya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160206/
https://www.ncbi.nlm.nih.gov/pubmed/35226140
http://dx.doi.org/10.1007/s00345-022-03947-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160206/
https://www.ncbi.nlm.nih.gov/pubmed/35226140
http://dx.doi.org/10.1007/s00345-022-03947-y

Ejemplares similares